ArticleJournal for immunotherapy of cancer2023

Zoledronic acid and thymosin α1 elicit antitumor immunity against prostate cancer by enhancing tumor inflammation and cytotoxic T cells.

Sheng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.